Compare
Silo Pharma, Inc. vs HCW Biologics Inc. vs BullFrog AI Holdings, Inc. vs Impact Biomedical Inc.
| Latest fiscal year | Silo Pharma, Inc. SILO | HCW Biologics Inc. HCWB | BullFrog AI Holdings, Inc. BFRG | Impact Biomedical Inc. IBO |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $72.1K | $54.2K | $116.7K | $32.0K |
| Revenue growth (YoY) | 0.0% | -97.9% | n/a | n/a |
| Gross margin | 38.6% | 20.0% | 18.8% | n/m (computed) |
| Operating margin | n/m | n/m | n/m | n/m |
| Net margin | n/m | n/m | n/m | n/m |
| Net income | -$4.23M | -$7.96M | -$6.50M | -$11.84M |
| EPS (Diluted) | -$0.50 | -$10.63 | -$0.63 | -$0.38 |
| Operating cash flow | -$4.66M | -$13.39M | -$5.52M | -$1.89M |
| Free cash flow | n/a | -$13.39M | n/a | n/a |
| Cash & equivalents | $4.75M | $1.95M | $2.18M | $3.0K |
| Total assets | $7.61M | $24.52M | $2.81M | $17.41M |
| Total liabilities | $1.30M | $21.76M | $672.0K | $1.85M |
| Shareholders' equity | $6.31M | $2.76M | $2.14M | $12.61M |
| Return on year-end equity | -67.0% | -287.9% | -304.2% | -93.9% |
| Shares outstanding | 13.32M | n/a | 11.42M | 104.62M |
Revenue, most recent five fiscal years
| Fiscal year | Silo Pharma, Inc. | HCW Biologics Inc. | BullFrog AI Holdings, Inc. | Impact Biomedical Inc. |
|---|---|---|---|---|
| Latest | $72.1K Ended 2025-12-31 | $54.2K Ended 2025-12-31 | $116.7K Ended 2025-12-31 | $32.0K Ended 2025-12-31 |
| 1 year earlier | $72.1K Ended 2024-12-31 | $2.57M Ended 2024-12-31 | n/a | n/a |
| 2 years earlier | $72.1K Ended 2023-12-31 | $2.84M Ended 2023-12-31 | $65.0K Ended 2023-12-31 | n/a |
| 3 years earlier | $72.1K Ended 2022-12-31 | $6.72M Ended 2022-12-31 | $10.0K Ended 2022-12-31 | $50.0K Ended 2022-12-31 |
| 4 years earlier | n/a | $0 Ended 2021-12-31 | n/a | n/a |